Trial · NCT00563706
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Placebo | 94.74 | Standard Deviation 11.18 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 50 mg | 94.24 | Standard Deviation 8.42 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 100 mg | 96.88 | Standard Deviation 14.54 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 150 mg | 101.33 | Standard Deviation 12.97 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 200 mg | 93.06 | Standard Deviation 8.84 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 300 mg | 94.39 | Standard Deviation 8.73 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 400 mg | 92.83 | Standard Deviation 10.25 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Vabicaserin 600 mg | 95.54 | Standard Deviation 12.46 | units on a scale | |
| Positive and Negative Symptom Scale (PANSS) Total Score at Baseline | Risperidone | 91.43 | Standard Deviation 10.83 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Placebo | -17.03 | Standard Error 3.59 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 50 mg | -4.72 | Standard Error 4.87 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 100 mg | -10.26 | Standard Error 8.35 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 150 mg | -5.41 | Standard Error 5.18 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 200 mg | -13.42 | Standard Error 5.17 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 300 mg | -6.13 | Standard Error 4.80 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 400 mg | -13.84 | Standard Error 5.93 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Vabicaserin 600 mg | -7.30 | Standard Error 4.09 | units on a scale | |
| Change From Baseline in Positive and Negative Symptom Scale (PANSS) Total Score at Day 28 | Risperidone | -15.59 | Standard Error 3.20 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00563706/results